A Look Into Novel Diagnostics: Joe Mullings & Epic Sciences

A relentless mission in the battle of metastatic breast cancer.

It seems like all of us have direct experience or a single degree of separation from a person who is fighting the good fight.

I recently spoke with Mark Aguillard, the VP and GM, of the Oncology business unit of Epic Sciences │ The Power of Clarity

Epic has developed a technology platform that uses a single peripheral blood draw that is able to pick up diagnostic information that is shed from a tumor that otherwise requires multiple diagnostic pieces in a fragmented chain of activities in the current diagnostic chain of the patient journey.

Time, accuracy, and care. All are critical in this patient population.